InvestorsHub Logo
Followers 57
Posts 5700
Boards Moderated 0
Alias Born 12/13/2004

Re: None

Tuesday, 04/20/2021 10:27:38 AM

Tuesday, April 20, 2021 10:27:38 AM

Post# of 14951
Sorrento Announces Positive Results of Phase 1b Study of COVI-MSC™ Treatment of ICU Covid-19 Patients, Achieving 100% (10 out 10) Discharge Rate
4/20/21, 9:00 AM
• The target enrollment of 10 patients with acute respiratory failure due to COVID-19 has been accomplished.
• All 10 patients were discharged from hospital within three days after their last COVI-MSC infusion.
• No infusion-related adverse events were observed.
• Sorrento plans a pivotal, multi-country, multi-site, placebo-controlled study to support an EUA submission."

They plan a PIVOTAL TRIAL likely in US, Brazil and Mexico!

"The refusal of the real is the number one dogma of our time" Rene Girard

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SRNE News